Biogen Inc. buy Royal Bank of Canada
Start price
25.06.25
/
50%
€108.75
Target price
25.06.26
€183.16
Performance (%)
52.18%
Price
13.02.26
€165.50
Summary
This prediction is currently active. With a performance of 52.18% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 25.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -2.733% | -2.733% |
| iShares Core DAX® | 0,46 % | -2,00 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % |
| iShares S&P 500 | -1,76 % | -3,67 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank Of Canada from $205.00 to $213.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat